https://www.indianpharmapost.com/chemcon-q2-fy23-revenue-down-54-profit-down-466-132912022-11-14T00:00:00+05:30always0.9https://www.indianpharmapost.com/gl-chemtech-appoints-dr-john-warner-as-green-chemistry-innovation-advisor-132922022-11-14T00:00:00+05:30always0.9https://www.indianpharmapost.com/suven-life-sciences-posts-q2fy23-consolidated-loss-at-rs-2318-cr-132932022-11-14T00:00:00+05:30always0.9https://www.indianpharmapost.com/supriya-lifescience-q2-fy2023-profit-slips-to-rs-1686-cr-132942022-11-14T00:00:00+05:30always0.9https://www.indianpharmapost.com/biocon-biologics-features-on-asia-ip-elite-list-2022-132952022-11-14T00:00:00+05:30always0.9https://www.indianpharmapost.com/gsk-india-announces-9-sales-growth-across-general-medicines-and-specialty-business-132962022-11-14T00:00:00+05:30always0.9https://www.indianpharmapost.com/aurobindo-pharma-q2-fy23-revenue-down-34-132972022-11-14T00:00:00+05:30always0.9https://www.indianpharmapost.com/alembic-receives-usfda-final-approval-for-cyclophosphamide-capsules-132982022-11-14T00:00:00+05:30always0.9https://www.indianpharmapost.com/stelis-receives-recommendation-from-ema-granting-market-authorization-for-kauliv-132992022-11-14T00:00:00+05:30always0.9